Status:
UNKNOWN
Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
Lead Sponsor:
Queen's University, Belfast
Collaborating Sponsors:
University of Sussex
Conditions:
Low Vision
Retinitis Pigmentosa
Eligibility:
All Genders
20-50 years
Brief Summary
Purpose: To validate a newly developed battery of performance-based tests of visual function to be presented using virtual reality. The tests are intended as potential outcome measures for clinical t...
Detailed Description
Aims of the Research Project: 1. To validate a new virtual reality (VR)-based battery of performance-based tests of visual function that are relevant for patients' daily lives. 2. To quantify the rep...
Eligibility Criteria
Inclusion
- Male and female participants
- Age 20-50
- Bilateral sight impairment due to Stargardt's disease, retinitis pigmentosa or albinism.
- Sight impairment criteria are as follows:
- Visual acuity of 3 / 60 to 6 / 60 with a full field of vision.
- Visual acuity of up to 6 / 24 with a moderate reduction of field of vision
Exclusion
- Any physical impairment that would make use of the virtual reality headset difficult or unsafe.
- A history of vertigo or dizziness.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04281732
Start Date
October 1 2018
End Date
December 31 2020
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NI Clinical Research Facility
Belfast, Northern Ireland, United Kingdom, BT9 7AB